Saturna Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-19,209
Closed -$377K – 160
2022
Q2
$377K Hold
19,209
– – 0.01% 134
2022
Q1
$501K Hold
19,209
– – 0.01% 126
2021
Q4
$545K Hold
19,209
– – 0.01% 127
2021
Q3
$613K Hold
19,209
– – 0.01% 121
2021
Q2
$666K Hold
19,209
– – 0.01% 122
2021
Q1
$566K Hold
19,209
– – 0.01% 124
2020
Q4
$589K Hold
19,209
– – 0.01% 125
2020
Q3
$537K Hold
19,209
– – 0.01% 120
2020
Q2
$412K Buy
19,209
+4,000
+26% +$88.4K 0.01% 130
2020
Q1
$341K Hold
15,209
– – 0.01% 140
2019
Q4
$448K Sell
15,209
-920
-6% -$25K 0.01% 139
2019
Q3
$429K Hold
16,129
– – 0.01% 139
2019
Q2
$545K Buy
16,129
+3,300
+26% +$107K 0.02% 120
2019
Q1
$411K Buy
+12,829
New +$395K 0.01% 128

Other funds holding ELAN

Saturna Capital's ELAN Position: Q3 2022 in Review

Saturna Capital sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 19,209 shares — an estimated $377K sold.

Saturna Capital first reported a position in ELAN in Q1 2019 and held it in 14 quarters. The position peaked at $666K in Q2 2021. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • Saturna Capital reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
  • Saturna Capital sold 19,209 Elanco Animal Health shares in Q3 2022, an estimated $377K.
  • Saturna Capital first reported a position in Elanco Animal Health in Q1 2019 and held it in 14 quarters.
  • Saturna Capital's Elanco Animal Health position peaked at $666K in Q2 2021.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Saturna Capital's 13F filing for Q3 2022, filed 10 Nov 2022.